Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on April 30, 2009

Stroke. 2009
Published online before print April 30, 2009, doi: 10.1161/STROKEAHA.108.537654
A more recent version of this article appeared on June 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/6/2275    most recent
STROKEAHA.108.537654v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, S. M.
Right arrow Articles by Donnan, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, S. M.
Right arrow Articles by Donnan, G. A.
Related Collections
Right arrow Antiplatelets

Submitted on September 18, 2008
Accepted on October 1, 2008

Antiplatelet Activity

Stephen M. Davis MD, FRACP* and Geoffrey A. Donnan MD, FRACP

From Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

* To whom correspondence should be addressed. E-mail: stephen.davis{at}mh.org.au.
Key words: antiplatelet RX • antiplatelet • secondary prevention • ischemic stroke






Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.